BCI companies currently focusing on developing an implantable visual prosthesis will soon shift their focus toward more general neuromodulation use cases to reach economy of scale and recoup investments.
The claim that BCI (brain-computer interface) companies specializing in implantable visual prostheses are poised to pivot toward broader neuromodulation applications—for conditions like depression, chronic pain, Parkinson's, or cognitive enhancement—aligns with emerging industry trends. This shift would indeed help achieve economies of scale by targeting larger patient populations and accelerating investment recovery, as visual restoration remains a niche market (affecting an estimated 2.2 …
@seeingwithsound@mas.to